GIORGINO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 20.745
EU - Europa 6.309
AS - Asia 3.604
SA - Sud America 389
AF - Africa 25
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 31.093
Nazione #
US - Stati Uniti d'America 20.704
CN - Cina 1.895
IT - Italia 1.321
SE - Svezia 1.253
SG - Singapore 1.247
RU - Federazione Russa 1.022
UA - Ucraina 784
DE - Germania 708
FI - Finlandia 471
BR - Brasile 348
GB - Regno Unito 297
FR - Francia 132
ID - Indonesia 118
IN - India 108
BE - Belgio 82
IE - Irlanda 66
VN - Vietnam 63
AT - Austria 60
HK - Hong Kong 48
NL - Olanda 41
CA - Canada 27
TR - Turchia 16
CH - Svizzera 14
KR - Corea 14
IQ - Iraq 12
CZ - Repubblica Ceca 11
JP - Giappone 11
LT - Lituania 10
AU - Australia 9
BD - Bangladesh 9
PE - Perù 9
IR - Iran 8
UZ - Uzbekistan 8
VE - Venezuela 8
EU - Europa 7
GR - Grecia 7
MA - Marocco 7
PK - Pakistan 7
AR - Argentina 6
TN - Tunisia 6
BG - Bulgaria 5
EC - Ecuador 5
BZ - Belize 4
CL - Cile 4
HU - Ungheria 4
KE - Kenya 4
LB - Libano 4
NP - Nepal 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
BO - Bolivia 3
CO - Colombia 3
DO - Repubblica Dominicana 3
ES - Italia 3
GE - Georgia 3
MX - Messico 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PL - Polonia 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AM - Armenia 2
KG - Kirghizistan 2
NG - Nigeria 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
TW - Taiwan 2
AL - Albania 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MC - Monaco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 31.093
Città #
Fairfield 2.561
Woodbridge 2.143
Jacksonville 1.868
Chandler 1.866
Houston 1.457
Ashburn 1.226
Cambridge 1.051
Ann Arbor 973
Nyköping 969
Seattle 952
Wilmington 804
Singapore 696
Roxbury 508
Lawrence 499
Dearborn 483
Nanjing 466
Bari 330
Des Moines 303
Boardman 292
Beijing 287
New York 254
Inglewood 178
Princeton 175
San Diego 133
Nanchang 130
Hebei 125
Shenyang 111
Jakarta 110
Brooklyn 100
Moscow 84
Jiaxing 83
Brussels 82
Helsinki 77
Los Angeles 77
London 75
Tianjin 75
Santa Clara 72
Dong Ket 63
Dublin 63
Guangzhou 61
Hefei 59
Pune 59
Paris 58
Jinan 54
Changsha 53
Nuremberg 49
Redwood City 49
Kunming 43
Hong Kong 42
Rome 40
Munich 38
Falkenstein 34
Norwalk 27
Zhengzhou 27
Auburn Hills 25
Vienna 25
Hyderabad 24
São Paulo 24
Frankfurt am Main 22
Washington 20
Falls Church 19
Wuhan 19
Shanghai 18
Trinitapoli 18
Chicago 17
Mola Di Bari 17
Altay 16
Naples 16
Milan 15
Hounslow 14
Amsterdam 13
Council Bluffs 13
Belo Horizonte 12
Fuzhou 12
Hangzhou 12
Rio de Janeiro 11
Taizhou 11
Kilburn 10
San Jose 10
Augusta 9
Grafing 9
Lima 9
Ottawa 9
Chongqing 8
Toronto 8
Xian 8
Zurich 8
Jinhua 7
Ningbo 7
Palermo 7
Saint Petersburg 7
Shenzhen 7
Turin 7
Vignola 7
Acton 6
Baghdad 6
Buffalo 6
Chengdu 6
Curitiba 6
Herne 6
Totale 23.060
Nome #
Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy 179
Wound healing in diabetes: hemorheological and microcirculatory aspects. 160
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial 159
Long-term exposure of pancreatic β-cells to palmitate results in SREBP-1C-dependent decreases in GLP-1 receptor signaling via CREB and AKT and insulin secretory response 154
Italian consensus for the classification and reporting of thyroid cytology: the risk of malignancy between indeterminate lesions at low or high risk. A systematic review and meta-analysis 153
Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity 152
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 144
Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy 143
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 142
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases 138
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 135
GLP-1: a new approach for type 2 diabetes therapy 134
Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy 132
Abnormalities of insulin-like growth factor-l Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis 129
PKB/Akt and MAPK/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia 129
GLP-1 Receptor Agonist Added to Insulin versus Basal-plus or Basal-bolus Insulin Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis 126
Rare diseases in clinical endocrinology: A taxonomic classification system 125
Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysin63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy 119
Diabetes and cancer: pathophysiological fundamentals of a 'dangerous affair' 115
The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells 115
Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: an adiposity and autoimmune linkage? 115
Association between Follicular Fluid Leptin and Serum Insulin Levels in Nonoverweight Women with Polycystic Ovary Syndrome 114
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. 114
The p66Shc Protein Controls Redox Signaling and Oxidation-Dependent DNA Damage in Human Liver Cells 114
Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway. 112
Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan-L trial 112
GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells 111
Irisin Increases the Expression of Anorexigenic and Neurotrophic Genes in Mouse Brain 110
Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane 109
Insulin and Insulin Receptors in Adipose Tissue Development 109
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 109
Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis 109
Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment 108
The Sentiment Analysis of Tweets as a New Tool to Measure Public Perception of Male Erectile and Ejaculatory Dysfunctions 108
Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trial 107
Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism 106
Interventional therapy in diabetic foot: Risk factors, clinical events and prognosis at one year follow-up (a study of 103 cases) 105
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. 104
Heterogeneity and Similarities in GLP-1 Receptor Agonist Cardiovascular Outcomes Trials 104
A master course on "Methodologies for bio-medical research in diabetes". 103
Glucagon-Like Peptide-1 Counteracts Oxidative Stress-Dependent Apoptosis of Human Cardiac Progenitor Cells by Inhibiting the Activation of the c-Jun N-terminal Protein Kinase Signaling Pathway 103
Clinical view on the need to develop new anti-diabetic drugs 103
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. 102
Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome 101
Differences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and visceral adipose tissue in humans. 101
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. 101
The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study 101
Adipose Tissue Function and Dysfunction: Organ Cross-Talk and Metabolic Risk 100
Effect of family history of type 2 diabetes on white blood cell count in adult women 100
The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis 100
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 100
Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies 99
Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis. 99
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: A cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 99
Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia. 99
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study 97
NANOG plays a hierarchical role in the transcription network regulating the pluripotency and plasticity of adipose tissue-derived stem cells 97
Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: Clinical consequences and strategies for improvement 97
RAS/BRAF mutational status in familial non‑medullary thyroid carcinomas: A retrospective study 97
Efficacy and safety of once- weekly dulaglutide versus insulin glargine in patients with type 2 Diabetes on metformin and glimepiride (AWARD-2) 97
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 97
Exploiting the pleiotropic actions of GLP-1 for the management of type 2 diabetes mellitus and its complications. 96
A family history of Type 2 diabetes is associated with increased plasma levels of C-reactive protein in non-smoking healthy adult women 96
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 96
Low dehydroepiandrosterone circulating levels in premenopausal obese women with very high body mass index 95
Relationship between risk factors and mortality in type 1 diabetic patients in europe: The eurodiab prospective complications study (PCS) 95
Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts 94
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. 94
Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR study: similar effects of telecare and conventional self-monitoring of blood glucose on patient functional health status and treatment satisfaction. 94
Effects of Extra Virgin Olive Oil Polyphenols on Pancreatic Beta-Cell Function and Survival 94
Effects of CPAP on testosterone levels in patients with obstructive sleep apnea: a meta-analysis study 94
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study. 93
Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling 93
null 93
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study. 92
In vivo insulin signaling in the myocardium of streptozotocin-diabetic rats: opposite effects of diabetes on insulin stimulation of glycogen synthase and c-Fos 91
Effect of family history of type 2 diabetes on the intima-media thickness of the common carotid artery in normal-weight, overweight, and obese glucose-tolerant young adults 91
The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study 91
Pegvisomant in acromegaly: an update 91
TNFα Signals via p66(Shc) to Induce E-Selectin, Promote Leukocyte Transmigration and Enhance Permeability in Human Endothelial Cells 89
null 89
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 89
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 88
Glucose control and vascular outcomes in type 2 diabetes: Is the picture clear? 88
The IGF-I/IGF-I receptor pathway: implications in the pathophysiology of thyroid cancer. 87
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: A comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program 87
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes 87
PPAR-gamma agonisti nella terapia del diabete mellito e di altre malattie endocrino-metaboliche 86
The ultrasound assessment of adipose tissue deposition in fetuses of "well controlled" insulin-dependent diabetic pregnancies 86
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study 86
Decreased IRS phosphorylation and altered Erk activation in osteoblasts from osteoporotic subjects. 85
Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling 85
Efficacy of Vandetanib in treating locally advanced or metastatic medullary thyroid carcinoma according to RECIST Criteria: A systematic review and meta-analysis 85
IGF-I and IGF-I receptor: implications in the pathophysiology of thyroid cancer 84
Human adipose tissue precursor cells: a new factor linking regulation of fat mass to obesity and type 2 diabetes? 84
Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome 84
Gut: A key player in the pathogenesis of type 2 diabetes? 84
Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype 83
Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study. 83
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010". 82
Totale 10.540
Categoria #
all - tutte 150.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.350 0 0 0 0 0 0 0 0 0 537 663 150
2020/20214.560 424 234 440 174 646 194 561 387 451 558 246 245
2021/20223.384 128 468 31 214 127 179 106 200 252 222 581 876
2022/20235.254 761 491 261 471 651 762 78 575 978 40 101 85
2023/20241.834 158 380 107 128 179 413 39 157 23 50 13 187
2024/20254.348 128 124 710 295 233 907 667 825 445 14 0 0
Totale 32.191